30 filings
Page 2 of 2
8-K
osnd3mnu 9s
1 Dec 22
Pyxis Oncology Announces FDA Clearance of Two IND Applications
7:03am
8-K
zuyf vt4z
1 Nov 22
Expands worldwide licensing agreement with Pfizer to obtain additional antibody-drug conjugate (ADC) platform components
7:14am
8-K
pybbd
7 Oct 22
Entry into a Material Definitive Agreement
4:30pm
8-K
vdgca7nuugpajisr
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am
8-K
z6kb qiqp
9 Aug 22
Departure of Directors or Certain Officers
12:00am
8-K
isrsoaz9
14 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
6m6v7
13 May 22
Results of Operations and Financial Condition
8:12am
8-K
i0grqyx83
14 Apr 22
Pyxis Oncology Announces Leadership Changes
5:11pm
8-K
0mb6j
29 Mar 22
Pyxis Oncology Provides Corporate and Financial Update
7:31am
8-K
mm3r8 7zsvwf07ea4on
15 Nov 21
Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update
7:39am